ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR was reported 3278 times

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMATOLOGY TEST NORMAL 3 0.6000
1 FOLLICULAR LYMPHOMA REFRACTORY 5 0.0769
2 URETERIC HAEMORRHAGE 5 0.0725
3 TESTICULAR OPERATION 4 0.0714
4 GRIP STRENGTH 13 0.0568
5 DENGUE HAEMORRHAGIC FEVER 3 0.0469
6 NASAL HERPES 8 0.0394
7 HEPATIC ENZYME 5 0.0336
8 HYPOAESTHESIA EYE 19 0.0322
9 HAEMORRHAGIC HEPATIC CYST 3 0.0316
10 ACTION TREMOR 5 0.0309
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 20 0.0299
12 FOETAL CHROMOSOME ABNORMALITY 5 0.0294
13 STEROID DEPENDENCE 23 0.0262
14 REDUCED FACIAL EXPRESSION 26 0.0256
15 DEEP VEIN THROMBOSIS POSTOPERATIVE 49 0.0245
16 CATARRH 22 0.0243
17 LUPUS VULGARIS 29 0.0230
18 C-REACTIVE PROTEIN 21 0.0227
19 FACET JOINT SYNDROME 70 0.0215
20 RHEUMATIC FEVER 90 0.0202
21 SWOLLEN JOINT COUNT INCREASED 64 0.0201
22 SWOLLEN JOINT COUNT 5 0.0200
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 11 0.0196
24 MERALGIA PARAESTHETICA 4 0.0190
25 X-RAY ABNORMAL 33 0.0184
26 NEUROLOGIC NEGLECT SYNDROME 10 0.0180
27 TRANSFERRIN SATURATION DECREASED 7 0.0164
28 DUODENAL ULCER PERFORATION 120 0.0161
29 NIPPLE SWELLING 4 0.0159
30 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 33 0.0159
31 PERIPHERAL VENOUS DISEASE 60 0.0147
32 RETINITIS 25 0.0145
33 DISLOCATION OF VERTEBRA 33 0.0145
34 MEAN PLATELET VOLUME DECREASED 12 0.0143
35 HYPOCHOLESTEROLAEMIA 5 0.0142
36 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
37 ABDOMINAL LYMPHADENOPATHY 12 0.0138
38 AUTOIMMUNE NEPHRITIS 3 0.0136
39 NEUTROPENIC INFECTION 13 0.0136
40 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 95 0.0132
41 ANTIPSYCHOTIC DRUG LEVEL DECREASED 7 0.0132
42 RHEUMATOID FACTOR POSITIVE 74 0.0128
43 BLISTER INFECTED 10 0.0128
44 PORPHYRIA ACUTE 18 0.0125
45 BURNS SECOND DEGREE 22 0.0125
46 MUSCLE INJURY 103 0.0124
47 MONOCYTE COUNT DECREASED 15 0.0123
48 C-REACTIVE PROTEIN DECREASED 8 0.0123
49 HELICOBACTER INFECTION 124 0.0121
50 FOLLICULITIS 126 0.0120
51 CAROTID ARTERY THROMBOSIS 10 0.0118
52 C-REACTIVE PROTEIN ABNORMAL 74 0.0115
53 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 74 0.0114
54 IMMUNODEFICIENCY COMMON VARIABLE 5 0.0102
55 LISTLESS 33 0.0100
56 PEMPHIGUS 125 0.0100
57 HAND DEFORMITY 128 0.0097
58 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
59 ALCOHOL POISONING 23 0.0086
60 PERICARDITIS 139 0.0083
61 LIP DRY 74 0.0081
62 ONYCHOMADESIS 34 0.0081
63 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
64 ONYCHOMYCOSIS 35 0.0080
65 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 13 0.0078
66 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 5 0.0078
67 ADJUSTMENT DISORDER 10 0.0077
68 VESTIBULAR NEURONITIS 4 0.0075
69 HYPERCHOLESTEROLAEMIA 72 0.0074
70 BREAST CANCER STAGE III 48 0.0074
71 SYNOVITIS 130 0.0072
72 JOINT RANGE OF MOTION DECREASED 88 0.0066
73 HYPOPNOEA 22 0.0063
74 GRIP STRENGTH DECREASED 55 0.0062
75 BONE EROSION 22 0.0062
76 ARTERIOVENOUS FISTULA 3 0.0061
77 BURSITIS 72 0.0059
78 STREPTOCOCCAL SEPSIS 7 0.0059
79 GLOSSODYNIA 128 0.0057
80 FACIAL DISCOMFORT 4 0.0056
81 IRRITABLE BOWEL SYNDROME 119 0.0055
82 WOUND INFECTION 60 0.0055
83 CHIKUNGUNYA VIRUS INFECTION 3 0.0054
84 LIVE BIRTH 44 0.0053
85 AUTOIMMUNE DISORDER 49 0.0050
86 WOUND 137 0.0049
87 IMMOBILE 21 0.0048
88 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
89 SYSTEMIC LUPUS ERYTHEMATOSUS 170 0.0048
90 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
91 MEDICATION OVERUSE HEADACHE 4 0.0047
92 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
93 FOREIGN BODY 18 0.0045
94 FACIAL SPASM 5 0.0045
95 VULVOVAGINAL CANDIDIASIS 6 0.0044
96 FIBROMYALGIA 104 0.0043
97 BLEPHAROSPASM 26 0.0041
98 PRODUCT LABEL CONFUSION 24 0.0041
99 IMPAIRED HEALING 135 0.0041
100 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
101 OBESITY 65 0.0041
102 BRAIN STEM SYNDROME 3 0.0040
103 LIVER INJURY 98 0.0040
104 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
105 PERIARTHRITIS 9 0.0040
106 TROPONIN T INCREASED 5 0.0039
107 PARAINFLUENZAE VIRUS INFECTION 6 0.0039
108 EYE COLOUR CHANGE 4 0.0039
109 SCIATICA 61 0.0038
110 PERSONALITY DISORDER 10 0.0038
111 SYSTOLIC DYSFUNCTION 4 0.0038
112 TUMOUR PAIN 5 0.0038
113 FINGER DEFORMITY 18 0.0037
114 URETERIC OBSTRUCTION 5 0.0037
115 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
116 METABOLIC SYNDROME 6 0.0036
117 AFFECT LABILITY 35 0.0036
118 NAIL DISORDER 31 0.0035
119 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
120 TYPE 2 DIABETES MELLITUS 118 0.0035
121 SERONEGATIVE ARTHRITIS 4 0.0035
122 PELVIC FRACTURE 27 0.0035
123 BRONCHIECTASIS 23 0.0034
124 LOWER RESPIRATORY TRACT INFECTION 149 0.0033
125 LIVER FUNCTION TEST INCREASED 69 0.0032
126 PAROSMIA 24 0.0032
127 TESTICULAR SWELLING 4 0.0032
128 RHINITIS 25 0.0031
129 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
130 STOMA SITE INFECTION 4 0.0031
131 GINGIVAL PAIN 24 0.0030
132 LOWER LIMB FRACTURE 57 0.0030
133 EYE INJURY 9 0.0030
134 PSORIATIC ARTHROPATHY 120 0.0030
135 PUSTULAR PSORIASIS 10 0.0029
136 RASH VESICULAR 14 0.0029
137 HYPOPITUITARISM 5 0.0029
138 COELIAC DISEASE 28 0.0029
139 HYPERKINESIA 6 0.0028
140 CARDIAC MURMUR 24 0.0028
141 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
142 EXOSTOSIS 25 0.0027
143 DELIRIUM 94 0.0027
144 GAIT INABILITY 88 0.0026
145 PULMONARY FIBROSIS 50 0.0026
146 APATHY 38 0.0026
147 PRESCRIBED OVERDOSE 50 0.0026
148 C-REACTIVE PROTEIN INCREASED 94 0.0026
149 WALKING AID USER 17 0.0026
150 NORMAL NEWBORN 14 0.0026
151 ESCHERICHIA TEST POSITIVE 3 0.0025
152 DRUG TOLERANCE DECREASED 7 0.0025
153 VASOPLEGIA SYNDROME 4 0.0024
154 INFUSION RELATED REACTION 161 0.0024
155 HYPERPARATHYROIDISM 5 0.0024
156 FRACTURED SACRUM 3 0.0024
157 BAND SENSATION 3 0.0024
158 JOINT DISLOCATION 25 0.0024
159 BLOOD CHOLESTEROL INCREASED 110 0.0024
160 MYOSITIS 21 0.0023
161 SERUM FERRITIN DECREASED 4 0.0023
162 BACK INJURY 25 0.0023
163 CONTRAINDICATED PRODUCT ADMINISTERED 68 0.0022
164 ULCER HAEMORRHAGE 15 0.0022
165 CUSHINGOID 7 0.0022
166 CALCIPHYLAXIS 4 0.0022
167 NIGHT SWEATS 70 0.0022
168 HEMIPLEGIA 18 0.0022
169 OSTEOARTHRITIS 91 0.0021
170 HEPATIC ENZYME INCREASED 146 0.0021
171 STOMA SITE ERYTHEMA 4 0.0021
172 ARTHROPATHY 119 0.0021
173 CHRONIC SINUSITIS 8 0.0021
174 ALVEOLITIS 3 0.0021
175 BLISTER 119 0.0021
176 OROPHARYNGEAL DISCOMFORT 19 0.0021
177 MOBILITY DECREASED 150 0.0021
178 FOOT DEFORMITY 23 0.0021
179 FAT TISSUE INCREASED 3 0.0021
180 SCHIZOPHRENIA 25 0.0021
181 BREAST CANCER STAGE II 17 0.0020
182 GENERALISED ANXIETY DISORDER 3 0.0020
183 DISCOMFORT 124 0.0020
184 GANGRENE 12 0.0020
185 HEAD DISCOMFORT 35 0.0020
186 IMMUNE-MEDIATED HEPATITIS 4 0.0020
187 SPONDYLITIS 7 0.0019
188 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
189 LUPUS-LIKE SYNDROME 17 0.0019
190 ILL-DEFINED DISORDER 113 0.0019
191 ABSCESS INTESTINAL 4 0.0019
192 NIGHTMARE 64 0.0018
193 STOMA SITE DISCHARGE 5 0.0018
194 IMMUNODEFICIENCY 27 0.0018
195 FAECES PALE 4 0.0018
196 LIVER DISORDER 78 0.0018
197 FEMALE GENITAL TRACT FISTULA 3 0.0018
198 STOMATITIS 106 0.0017
199 INJURY 122 0.0017
200 GENERAL PHYSICAL HEALTH DETERIORATION 200 0.0017
201 EXTREMITY NECROSIS 3 0.0017
202 EMOTIONAL POVERTY 3 0.0017
203 WHEEZING 101 0.0017
204 SWELLING 156 0.0017
205 INFLAMMATION 86 0.0017
206 CEREBROVASCULAR DISORDER 5 0.0017
207 BONE MARROW DISORDER 5 0.0017
208 UTERINE LEIOMYOMA 12 0.0016
209 RETROPERITONEAL HAEMORRHAGE 4 0.0016
210 SLEEP DISORDER 114 0.0016
211 SENSORY LOSS 13 0.0016
212 INFLAMMATORY MARKER INCREASED 8 0.0016
213 BLOOD IRON DECREASED 19 0.0016
214 IMPAIRED QUALITY OF LIFE 23 0.0016
215 PREGNANCY 32 0.0016
216 HEPATIC CIRRHOSIS 30 0.0016
217 SQUAMOUS CELL CARCINOMA 15 0.0016
218 FREQUENT BOWEL MOVEMENTS 43 0.0016
219 CONFUSIONAL STATE 254 0.0016
220 MOTOR DYSFUNCTION 16 0.0016
221 MUSCULOSKELETAL PAIN 81 0.0015
222 SPINAL CORD COMPRESSION 6 0.0015
223 ABDOMINAL WALL HAEMATOMA 3 0.0015
224 LUNG DISORDER 75 0.0015
225 URINARY RETENTION 51 0.0015
226 TASTE DISORDER 31 0.0015
227 VITAMIN D DECREASED 13 0.0015
228 CEREBRAL ATROPHY 6 0.0015
229 POOR QUALITY SLEEP 32 0.0015
230 MUSCULOSKELETAL STIFFNESS 130 0.0015
231 OEDEMA 80 0.0015
232 NEUTROPHIL COUNT INCREASED 15 0.0015
233 PRESCRIBED UNDERDOSE 29 0.0015
234 LEFT VENTRICULAR FAILURE 5 0.0015
235 BEDRIDDEN 19 0.0014
236 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
237 ROAD TRAFFIC ACCIDENT 60 0.0014
238 CONTUSION 138 0.0014
239 PROCTITIS 4 0.0014
240 DILATATION VENTRICULAR 3 0.0014
241 GASTROINTESTINAL DISORDER 127 0.0014
242 SEDATION 37 0.0014
243 RHEUMATOID ARTHRITIS 160 0.0014
244 UROSEPSIS 13 0.0014
245 ABSCESS LIMB 6 0.0014
246 CARDIAC FAILURE CHRONIC 6 0.0014
247 FIBRIN D DIMER INCREASED 5 0.0014
248 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
249 PYODERMA GANGRENOSUM 5 0.0014
250 MUSCLE SPASTICITY 17 0.0014
251 THORACIC VERTEBRAL FRACTURE 4 0.0014
252 FREEZING PHENOMENON 5 0.0013
253 JOINT SWELLING 163 0.0013
254 PERIORBITAL OEDEMA 7 0.0013
255 FEAR OF DEATH 3 0.0013
256 GENERAL SYMPTOM 10 0.0013
257 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
258 HEPATIC NECROSIS 5 0.0013
259 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
260 TROPONIN INCREASED 10 0.0013
261 DENGUE FEVER 3 0.0013
262 LOCALISED OEDEMA 6 0.0013
263 DRY MOUTH 105 0.0013
264 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
265 RHINOVIRUS INFECTION 5 0.0013
266 ADVERSE REACTION 17 0.0013
267 MEDICATION ERROR 71 0.0013
268 BLOOD CREATININE DECREASED 4 0.0013
269 ESCHERICHIA BACTERAEMIA 3 0.0013
270 DRUG-INDUCED LIVER INJURY 40 0.0013
271 LIVER FUNCTION TEST ABNORMAL 37 0.0013
272 TESTICULAR PAIN 4 0.0013
273 NEUTROPENIC SEPSIS 9 0.0013
274 POLYMYALGIA RHEUMATICA 4 0.0013
275 LYMPHOCYTE COUNT DECREASED 22 0.0012
276 HAEMOGLOBIN ABNORMAL 8 0.0012
277 NEUROLOGICAL SYMPTOM 7 0.0012
278 ANAL INCONTINENCE 11 0.0012
279 DERMAL CYST 3 0.0012
280 MYOCARDITIS 14 0.0012
281 OTITIS MEDIA 4 0.0012
282 CONGESTIVE CARDIOMYOPATHY 5 0.0012
283 RECTAL HAEMORRHAGE 51 0.0012
284 BRADYKINESIA 7 0.0012
285 THERAPEUTIC PRODUCT EFFECT DECREASED 53 0.0012
286 HEPATIC CYST 4 0.0012
287 PNEUMONITIS 32 0.0012
288 CANCER PAIN 3 0.0012
289 FACIAL PARALYSIS 10 0.0012
290 HEPATITIS 30 0.0012
291 FEMORAL NECK FRACTURE 6 0.0012
292 FOOD ALLERGY 9 0.0012
293 VERTIGO 71 0.0012
294 INTENTIONAL PRODUCT USE ISSUE 102 0.0012
295 PLATELET COUNT INCREASED 15 0.0011
296 COMPARTMENT SYNDROME 3 0.0011
297 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
298 ENCEPHALOPATHY 28 0.0011
299 JAUNDICE CHOLESTATIC 4 0.0011
300 EXPOSURE DURING PREGNANCY 70 0.0011
301 OVERWEIGHT 6 0.0011
302 MATERNAL EXPOSURE DURING PREGNANCY 99 0.0011
303 HIP ARTHROPLASTY 17 0.0011
304 KNEE ARTHROPLASTY 23 0.0011
305 HYPERTENSION 230 0.0011
306 SINUSITIS 111 0.0011
307 PERFORMANCE STATUS DECREASED 5 0.0011
308 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
309 FRACTURE 20 0.0011
310 CLAVICLE FRACTURE 4 0.0010
311 BLOOD URIC ACID INCREASED 6 0.0010
312 MIGRAINE 99 0.0010
313 COMA SCALE ABNORMAL 3 0.0010
314 THROAT TIGHTNESS 28 0.0010
315 RALES 6 0.0010
316 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
317 HYPONATRAEMIA 58 0.0010
318 SPLENOMEGALY 12 0.0010
319 EPILEPSY 31 0.0010
320 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
321 BLADDER DISORDER 10 0.0010
322 INJECTION SITE INFLAMMATION 5 0.0010
323 HYPERAMMONAEMIA 5 0.0010
324 BLEPHARITIS 4 0.0010
325 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
326 HYPOAESTHESIA 148 0.0010
327 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
328 COLITIS ULCERATIVE 44 0.0010
329 RESTLESSNESS 36 0.0010
330 HYPERSENSITIVITY 182 0.0010
331 EAR INFECTION 26 0.0010
332 IRON DEFICIENCY ANAEMIA 9 0.0010
333 SELF-MEDICATION 4 0.0010
334 ABDOMINAL DISCOMFORT 163 0.0010
335 CHOLANGITIS 6 0.0010
336 FOETAL DEATH 5 0.0010
337 INFECTION 139 0.0010
338 BLOOD BLISTER 3 0.0010
339 HAEMATOCRIT DECREASED 19 0.0010
340 PALLOR 26 0.0010
341 HAEMOGLOBIN DECREASED 98 0.0010
342 NECK PAIN 53 0.0009
343 SKIN HAEMORRHAGE 14 0.0009
344 HEMIPARESIS 16 0.0009
345 SWOLLEN TONGUE 29 0.0009
346 PYREXIA 321 0.0009
347 STRESS FRACTURE 5 0.0009
348 OXYGEN SATURATION DECREASED 52 0.0009
349 BACK DISORDER 15 0.0009
350 COGNITIVE DISORDER 43 0.0009
351 BOWEL MOVEMENT IRREGULARITY 7 0.0009
352 RED BLOOD CELL COUNT DECREASED 26 0.0009
353 INTESTINAL ISCHAEMIA 5 0.0009
354 CONGENITAL ANOMALY 7 0.0009
355 PARAESTHESIA ORAL 13 0.0009
356 CYTOKINE RELEASE SYNDROME 18 0.0009
357 EMPHYSEMA 9 0.0009
358 IRON DEFICIENCY 4 0.0009
359 POSTOPERATIVE WOUND INFECTION 6 0.0009
360 SINUS CONGESTION 12 0.0009
361 RESPIRATORY TRACT CONGESTION 14 0.0009
362 DRUG INTOLERANCE 85 0.0009
363 HERNIA 17 0.0009
364 NEUTROPHILIA 5 0.0009
365 LUMBAR VERTEBRAL FRACTURE 4 0.0009
366 BLOOD CREATININE ABNORMAL 3 0.0009
367 HYPOKALAEMIA 40 0.0009
368 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
369 AORTIC STENOSIS 3 0.0009
370 RENAL FUNCTION TEST ABNORMAL 4 0.0009
371 METABOLIC DISORDER 5 0.0009
372 COORDINATION ABNORMAL 12 0.0009
373 FEBRILE NEUTROPENIA 57 0.0009
374 HYPOVOLAEMIA 5 0.0009
375 INCONTINENCE 9 0.0009
376 IMPAIRED WORK ABILITY 18 0.0008
377 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
378 JOINT STIFFNESS 22 0.0008
379 BREAST CANCER METASTATIC 9 0.0008
380 ANGINA PECTORIS 24 0.0008
381 PERIPHERAL SWELLING 129 0.0008
382 TUMOUR MARKER INCREASED 4 0.0008
383 INGUINAL HERNIA 5 0.0008
384 ACCIDENTAL OVERDOSE 30 0.0008
385 ORAL HERPES 16 0.0008
386 FOOD INTOLERANCE 3 0.0008
387 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
388 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
389 AMNESIA 53 0.0008
390 ALCOHOL USE 3 0.0008
391 AMYLASE INCREASED 3 0.0008
392 OEDEMA PERIPHERAL 99 0.0008
393 MYOPATHY 7 0.0008
394 FOOT OPERATION 4 0.0008
395 NASOPHARYNGITIS 148 0.0008
396 HEPATIC ENZYME ABNORMAL 4 0.0008
397 ARTHRITIS 63 0.0008
398 TREATMENT FAILURE 66 0.0008
399 ERYSIPELAS 4 0.0008
400 CORONARY ARTERY STENOSIS 4 0.0008
401 VULVOVAGINAL PRURITUS 4 0.0008
402 DYSPEPSIA 77 0.0008
403 THERAPY NON-RESPONDER 35 0.0008
404 MUSCULOSKELETAL CHEST PAIN 12 0.0008
405 EAR PAIN 15 0.0008
406 SKIN NECROSIS 4 0.0008
407 TONSILLITIS 4 0.0008
408 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
409 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
410 LETHARGY 44 0.0008
411 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
412 HYPOGAMMAGLOBULINAEMIA 5 0.0008
413 HYPERTHYROIDISM 11 0.0008
414 ORAL CANDIDIASIS 10 0.0008
415 POLYARTHRITIS 4 0.0008
416 DISABILITY 15 0.0008
417 SERUM FERRITIN INCREASED 4 0.0008
418 MUSCULAR WEAKNESS 86 0.0008
419 URTICARIA 126 0.0008
420 MALIGNANT MELANOMA 10 0.0007
421 POST-TRAUMATIC STRESS DISORDER 5 0.0007
422 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
423 DECREASED APPETITE 170 0.0007
424 ARTHRITIS BACTERIAL 3 0.0007
425 EYE MOVEMENT DISORDER 5 0.0007
426 OSTEOPOROSIS 30 0.0007
427 ECCHYMOSIS 5 0.0007
428 ACUTE CORONARY SYNDROME 6 0.0007
429 DIVERTICULITIS 20 0.0007
430 ALOPECIA 140 0.0007
431 PAIN IN EXTREMITY 210 0.0007
432 URINARY INCONTINENCE 21 0.0007
433 ASTHMA 80 0.0007
434 HAEMATOCHEZIA 39 0.0007
435 APHASIA 21 0.0007
436 MOUTH SWELLING 4 0.0007
437 ATRIAL FIBRILLATION 67 0.0007
438 BODY TEMPERATURE INCREASED 14 0.0007
439 DYSPHEMIA 3 0.0007
440 WEIGHT INCREASED 153 0.0007
441 SPINAL PAIN 8 0.0007
442 HAEMORRHAGIC ANAEMIA 3 0.0007
443 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
444 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
445 METASTASES TO BONE 11 0.0007
446 CHEST PAIN 124 0.0007
447 RESPIRATORY DISORDER 20 0.0007
448 HAEMORRHOIDS 13 0.0007
449 MOUTH ULCERATION 14 0.0007
450 DYSARTHRIA 25 0.0007
451 NEURALGIA 16 0.0007
452 EATING DISORDER 14 0.0007
453 HAEMATOMA 17 0.0007
454 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
455 NERVE COMPRESSION 6 0.0006
456 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
457 ARTHRITIS INFECTIVE 3 0.0006
458 PHARYNGITIS 8 0.0006
459 HYPERHIDROSIS 83 0.0006
460 APPENDICITIS 6 0.0006
461 CONDITION AGGRAVATED 193 0.0006
462 RIB FRACTURE 13 0.0006
463 TINNITUS 29 0.0006
464 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
465 BLOOD ALBUMIN DECREASED 5 0.0006
466 HEPATIC FAILURE 19 0.0006
467 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
468 PANCREATITIS 33 0.0006
469 ATELECTASIS 6 0.0006
470 HEPATITIS ACUTE 4 0.0006
471 LIMB DISCOMFORT 19 0.0006
472 ASPHYXIA 5 0.0006
473 ESCHERICHIA INFECTION 5 0.0006
474 COLITIS 23 0.0006
475 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
476 SINUS DISORDER 12 0.0006
477 ABDOMINAL TENDERNESS 3 0.0006
478 HYPOACUSIS 26 0.0006
479 SKIN MASS 4 0.0006
480 ABDOMINAL PAIN UPPER 123 0.0006
481 MOOD SWINGS 19 0.0006
482 SUICIDE ATTEMPT 36 0.0006
483 METASTASES TO LYMPH NODES 4 0.0006
484 DYSLIPIDAEMIA 3 0.0006
485 HEPATIC STEATOSIS 11 0.0006
486 ENDOCARDITIS 3 0.0006
487 PHOTOPHOBIA 11 0.0006
488 HAEMATURIA 20 0.0006
489 TEMPERATURE INTOLERANCE 6 0.0006
490 HYPOCALCAEMIA 11 0.0006
491 RESPIRATION ABNORMAL 4 0.0006
492 SNEEZING 13 0.0006
493 TOOTH LOSS 12 0.0006
494 VENTRICULAR EXTRASYSTOLES 6 0.0006
495 DIPLOPIA 15 0.0006
496 ACUTE MYOCARDIAL INFARCTION 17 0.0006
497 CHROMATURIA 13 0.0006
498 APLASTIC ANAEMIA 3 0.0006
499 PARAESTHESIA 90 0.0006
500 RESPIRATORY DEPRESSION 7 0.0006
501 BLOOD CALCIUM INCREASED 5 0.0006
502 SPINAL OSTEOARTHRITIS 5 0.0006
503 HYPERCALCAEMIA 7 0.0006
504 NEPHROLITHIASIS 26 0.0006
505 LYMPHOPENIA 8 0.0006
506 PNEUMONIA 183 0.0006
507 CHOKING 11 0.0006
508 BONE PAIN 33 0.0006
509 SENSORY DISTURBANCE 9 0.0006
510 FACIAL PAIN 5 0.0006
511 PULMONARY OEDEMA 25 0.0006
512 FALL 185 0.0006
513 ANXIETY 158 0.0006
514 PALPITATIONS 65 0.0006
515 ABDOMINAL PAIN 129 0.0006
516 CHILLS 65 0.0006
517 ECZEMA 29 0.0006
518 DEEP VEIN THROMBOSIS 36 0.0006
519 DERMATITIS BULLOUS 4 0.0006
520 OPTIC NEURITIS 5 0.0005
521 SPINAL FRACTURE 11 0.0005
522 BLOOD GLUCOSE FLUCTUATION 6 0.0005
523 DEHYDRATION 73 0.0005
524 PULMONARY EMBOLISM 52 0.0005
525 MALAISE 239 0.0005
526 MUSCLE SPASMS 100 0.0005
527 AUTISM SPECTRUM DISORDER 3 0.0005
528 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
529 NERVOUS SYSTEM DISORDER 17 0.0005
530 ASCITES 16 0.0005
531 RASH 237 0.0005
532 ARTHRALGIA 226 0.0005
533 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
534 DYSURIA 20 0.0005
535 OVARIAN CANCER 5 0.0005
536 CARDIOMYOPATHY 8 0.0005
537 DEPRESSION 123 0.0005
538 TACHYCARDIA 48 0.0005
539 NERVE INJURY 6 0.0005
540 MEMORY IMPAIRMENT 74 0.0005
541 HEART RATE ABNORMAL 3 0.0005
542 BLOOD CALCIUM DECREASED 6 0.0005
543 INTENTIONAL OVERDOSE 34 0.0005
544 MOVEMENT DISORDER 17 0.0005
545 GAIT DISTURBANCE 101 0.0005
546 PAIN 324 0.0005
547 LIPASE INCREASED 4 0.0005
548 FEELING HOT 32 0.0005
549 EXERCISE TOLERANCE DECREASED 3 0.0005
550 VOMITING 244 0.0005
551 THROMBOCYTOPENIA 58 0.0005
552 SINUS BRADYCARDIA 5 0.0005
553 FEMUR FRACTURE 16 0.0005
554 ELECTROLYTE IMBALANCE 6 0.0005
555 CELLULITIS 26 0.0005
556 RETCHING 11 0.0005
557 LUNG INFECTION 8 0.0005
558 BASAL CELL CARCINOMA 8 0.0005
559 PHARYNGEAL SWELLING 5 0.0005
560 GASTROINTESTINAL INFLAMMATION 4 0.0005
561 AFFECTIVE DISORDER 4 0.0005
562 HEPATOMEGALY 5 0.0005
563 DYSPNOEA 288 0.0005
564 INJECTION SITE REACTION 35 0.0005
565 CHEST DISCOMFORT 52 0.0005
566 ABDOMINAL DISTENSION 53 0.0005
567 RENAL CYST 4 0.0005
568 TRICUSPID VALVE INCOMPETENCE 4 0.0005
569 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
570 FEELING COLD 14 0.0005
571 CYSTITIS 16 0.0005
572 HYPERLIPIDAEMIA 6 0.0005
573 GOUT 9 0.0005
574 INSOMNIA 133 0.0005
575 BLOOD DISORDER 4 0.0005
576 BLOOD TEST ABNORMAL 7 0.0005
577 DEVICE OCCLUSION 7 0.0005
578 TOOTHACHE 9 0.0005
579 MYASTHENIA GRAVIS 4 0.0005
580 MENTAL IMPAIRMENT 12 0.0005
581 VAGINAL DISCHARGE 5 0.0005
582 SUBARACHNOID HAEMORRHAGE 5 0.0005
583 CYTOPENIA 6 0.0005
584 HEADACHE 307 0.0005
585 ABNORMAL FAECES 4 0.0005
586 MYELODYSPLASTIC SYNDROME 7 0.0005
587 SPINAL COMPRESSION FRACTURE 4 0.0005
588 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
589 TENDERNESS 5 0.0005
590 INTENTIONAL PRODUCT MISUSE 42 0.0005
591 GASTROENTERITIS 7 0.0005
592 PETECHIAE 5 0.0005
593 INFUSION SITE ERYTHEMA 4 0.0005
594 BLOOD URINE PRESENT 9 0.0005
595 GASTRIC ULCER 9 0.0005
596 RENAL PAIN 5 0.0005
597 SLEEP APNOEA SYNDROME 9 0.0005
598 DYSGEUSIA 35 0.0005
599 SYNCOPE 47 0.0005
600 URINARY TRACT INFECTION 80 0.0005
601 HEREDITARY ANGIOEDEMA 5 0.0005
602 FATIGUE 362 0.0005
603 ARRHYTHMIA 22 0.0005
604 BLOOD MAGNESIUM DECREASED 4 0.0005
605 MUSCLE STRAIN 4 0.0005
606 PYELONEPHRITIS 4 0.0005
607 URINE OUTPUT DECREASED 4 0.0005
608 GROIN PAIN 4 0.0005
609 TUMOUR LYSIS SYNDROME 4 0.0005
610 SARS-COV-2 TEST POSITIVE 6 0.0005
611 HYPERSOMNIA 13 0.0005
612 IMMUNOSUPPRESSION 4 0.0005
613 FLUID RETENTION 23 0.0005
614 PURPURA 4 0.0005
615 ABORTION SPONTANEOUS 18 0.0004
616 ACUTE MYELOID LEUKAEMIA 7 0.0004
617 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
618 BACK PAIN 104 0.0004
619 HAEMOLYTIC ANAEMIA 4 0.0004
620 ADVERSE DRUG REACTION 40 0.0004
621 FEEDING DISORDER 9 0.0004
622 NAUSEA 350 0.0004
623 ASTHENIA 166 0.0004
624 PELVIC PAIN 8 0.0004
625 HYPERGLYCAEMIA 16 0.0004
626 SKIN LESION 12 0.0004
627 NEOPLASM 5 0.0004
628 HYPOTENSION 87 0.0004
629 ENCEPHALITIS 3 0.0004
630 RHINORRHOEA 28 0.0004
631 PRODUCT USE ISSUE 81 0.0004
632 EXTRASYSTOLES 3 0.0004
633 DEMENTIA 12 0.0004
634 RASH MACULAR 15 0.0004
635 HYPERKALAEMIA 15 0.0004
636 CHOLELITHIASIS 14 0.0004
637 FLANK PAIN 4 0.0004
638 WEIGHT DECREASED 119 0.0004
639 PHOTOSENSITIVITY REACTION 7 0.0004
640 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
641 HAND FRACTURE 3 0.0004
642 DIZZINESS 211 0.0004
643 SINUS TACHYCARDIA 6 0.0004
644 SPINAL DISORDER 4 0.0004
645 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
646 DEAFNESS 11 0.0004
647 FEAR OF INJECTION 3 0.0004
648 BRONCHOSPASM 6 0.0004
649 CHOLECYSTITIS 5 0.0004
650 SKIN DISCOLOURATION 19 0.0004
651 FLUID OVERLOAD 6 0.0004
652 BLOOD PRESSURE INCREASED 63 0.0004
653 CIRCULATORY COLLAPSE 7 0.0004
654 PARKINSONISM 4 0.0004
655 CEREBRAL INFARCTION 10 0.0004
656 MELAENA 9 0.0004
657 RASH MACULO-PAPULAR 9 0.0004
658 CATARACT 24 0.0004
659 PULMONARY MASS 6 0.0004
660 ILEUS 5 0.0004
661 TOOTH EXTRACTION 5 0.0004
662 RASH PAPULAR 9 0.0004
663 SECRETION DISCHARGE 5 0.0004
664 COLD SWEAT 7 0.0004
665 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
666 DRUG ERUPTION 7 0.0004
667 DYSKINESIA 16 0.0004
668 BALANCE DISORDER 34 0.0004
669 TOOTH ABSCESS 4 0.0004
670 ACIDOSIS 3 0.0004
671 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
672 MUSCLE TWITCHING 9 0.0004
673 OROPHARYNGEAL PAIN 36 0.0004
674 ANAEMIA 74 0.0004
675 SKIN ULCER 10 0.0004
676 DELUSION 6 0.0004
677 EJECTION FRACTION DECREASED 6 0.0004
678 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
679 UNINTENDED PREGNANCY 4 0.0004
680 NEUTROPENIA 52 0.0004
681 WEIGHT FLUCTUATION 4 0.0004
682 TRANSFUSION 4 0.0004
683 CYANOSIS 6 0.0004
684 IMMUNE SYSTEM DISORDER 5 0.0004
685 DRUG INTERACTION 60 0.0004
686 PRODUCT PRESCRIBING ERROR 9 0.0004
687 CEREBROVASCULAR ACCIDENT 64 0.0004
688 SEPSIS 42 0.0004
689 CONSTIPATION 82 0.0004
690 DIARRHOEA 241 0.0004
691 PRURITUS 143 0.0004
692 HALLUCINATION 28 0.0004
693 MUSCLE TIGHTNESS 6 0.0004
694 DYSPHAGIA 35 0.0004
695 DECUBITUS ULCER 3 0.0004
696 TACHYPNOEA 5 0.0004
697 SOMNOLENCE 74 0.0004
698 ACUTE RESPIRATORY FAILURE 7 0.0004
699 ANAPHYLACTIC REACTION 20 0.0004
700 AGGRESSION 18 0.0004
701 HYPERTENSIVE CRISIS 4 0.0004
702 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
703 SKIN INFECTION 4 0.0004
704 PRODUCTIVE COUGH 17 0.0004
705 ABDOMINAL PAIN LOWER 9 0.0004
706 RASH ERYTHEMATOUS 17 0.0004
707 HAEMATEMESIS 9 0.0004
708 MITRAL VALVE INCOMPETENCE 4 0.0004
709 PAIN IN JAW 10 0.0004
710 INFLUENZA LIKE ILLNESS 29 0.0004
711 MYOCARDIAL ISCHAEMIA 4 0.0004
712 MUSCULOSKELETAL DISCOMFORT 6 0.0003
713 METASTASES TO LUNG 4 0.0003
714 RESPIRATORY TRACT INFECTION 9 0.0003
715 PLEURAL EFFUSION 21 0.0003
716 SEPTIC SHOCK 15 0.0003
717 INFLUENZA 38 0.0003
718 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
719 LABORATORY TEST ABNORMAL 10 0.0003
720 COVID-19 PNEUMONIA 4 0.0003
721 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
722 ATAXIA 4 0.0003
723 PSORIASIS 44 0.0003
724 PULMONARY HYPERTENSION 7 0.0003
725 THIRST 6 0.0003
726 POLLAKIURIA 14 0.0003
727 MACULAR DEGENERATION 4 0.0003
728 WRIST FRACTURE 4 0.0003
729 RENAL IMPAIRMENT 28 0.0003
730 HYPOAESTHESIA ORAL 5 0.0003
731 CORONARY ARTERY DISEASE 10 0.0003
732 NOCTURIA 4 0.0003
733 JOINT INJURY 7 0.0003
734 DRUG DISPENSING ERROR 5 0.0003
735 SKIN CANCER 7 0.0003
736 PHARYNGEAL OEDEMA 5 0.0003
737 SMALL INTESTINAL OBSTRUCTION 4 0.0003
738 DEVICE RELATED INFECTION 5 0.0003
739 TENDON RUPTURE 4 0.0003
740 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
741 TENDONITIS 5 0.0003
742 ERYTHEMA MULTIFORME 3 0.0003
743 HAIR COLOUR CHANGES 4 0.0003
744 DEFORMITY 3 0.0003
745 PNEUMONIA ASPIRATION 8 0.0003
746 COVID-19 56 0.0003
747 NEUTROPHIL COUNT DECREASED 13 0.0003
748 PRODUCT USE COMPLAINT 5 0.0003
749 HEAD INJURY 10 0.0003
750 OFF LABEL USE 276 0.0003
751 STEVENS-JOHNSON SYNDROME 7 0.0003
752 VISUAL IMPAIRMENT 39 0.0003
753 MULTIPLE SCLEROSIS 15 0.0003
754 HYPOTHYROIDISM 10 0.0003
755 HYPOPHAGIA 8 0.0003
756 HEART RATE INCREASED 31 0.0003
757 POST PROCEDURAL COMPLICATION 6 0.0003
758 HYPOXIA 11 0.0003
759 HIP FRACTURE 10 0.0003
760 BRONCHITIS 23 0.0003
761 HEART RATE IRREGULAR 7 0.0003
762 HYPOGLYCAEMIA 15 0.0003
763 HIATUS HERNIA 4 0.0003
764 BLOOD POTASSIUM INCREASED 5 0.0003
765 PRODUCT AVAILABILITY ISSUE 7 0.0003
766 KIDNEY INFECTION 6 0.0003
767 ANKYLOSING SPONDYLITIS 4 0.0003
768 COUGH 85 0.0003
769 ABNORMAL BEHAVIOUR 12 0.0003
770 DEPRESSED MOOD 16 0.0003
771 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
772 VIRAL INFECTION 10 0.0003
773 BURNING SENSATION 21 0.0003
774 BRAIN INJURY 3 0.0003
775 BLOOD UREA INCREASED 5 0.0003
776 QUALITY OF LIFE DECREASED 4 0.0003
777 CANDIDA INFECTION 5 0.0003
778 DRY THROAT 3 0.0003
779 UVEITIS 4 0.0003
780 EPISTAXIS 22 0.0003
781 MYALGIA 50 0.0003
782 ANGIOEDEMA 13 0.0003
783 DYSPNOEA EXERTIONAL 11 0.0003
784 RESPIRATORY ARREST 8 0.0003
785 LOCALISED INFECTION 7 0.0003
786 ORAL DISCOMFORT 4 0.0003
787 HUNGER 4 0.0003
788 HAEMOPTYSIS 8 0.0003
789 SPEECH DISORDER 15 0.0003
790 METASTASES TO LIVER 5 0.0003
791 HALLUCINATION, VISUAL 6 0.0003
792 PLATELET COUNT DECREASED 30 0.0003
793 LOSS OF CONSCIOUSNESS 36 0.0003
794 BODY HEIGHT DECREASED 3 0.0003
795 GALLBLADDER DISORDER 5 0.0003
796 LEUKOPENIA 14 0.0003
797 CARDIOGENIC SHOCK 4 0.0003
798 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
799 FAECES DISCOLOURED 6 0.0003
800 DRUG ABUSE 23 0.0003
801 LEUKOCYTOSIS 5 0.0003
802 MENTAL DISORDER 12 0.0003
803 BONE DISORDER 5 0.0003
804 PANIC ATTACK 10 0.0003
805 DYSPHONIA 16 0.0003
806 OVERDOSE 59 0.0003
807 PANCYTOPENIA 15 0.0003
808 ACUTE KIDNEY INJURY 41 0.0003
809 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
810 HAEMORRHAGE INTRACRANIAL 4 0.0003
811 MUCOSAL INFLAMMATION 7 0.0003
812 RHABDOMYOLYSIS 11 0.0003
813 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
814 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
815 HERPES ZOSTER 15 0.0003
816 RESPIRATORY FAILURE 19 0.0003
817 JAUNDICE 7 0.0003
818 MENORRHAGIA 5 0.0003
819 ERYTHEMA 52 0.0003
820 BACTERAEMIA 3 0.0003
821 DISORIENTATION 10 0.0003
822 PNEUMOTHORAX 4 0.0003
823 COMA 12 0.0003
824 BLOOD PRESSURE ABNORMAL 5 0.0003
825 ULCER 4 0.0003
826 BLOOD PRESSURE FLUCTUATION 6 0.0002
827 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
828 CYTOMEGALOVIRUS INFECTION 4 0.0002
829 DRY EYE 12 0.0002
830 RASH PRURITIC 13 0.0002
831 DERMATITIS ALLERGIC 3 0.0002
832 NASAL CONGESTION 14 0.0002
833 CARDIAC FAILURE 19 0.0002
834 PARANOIA 4 0.0002
835 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
836 BLOOD CREATININE INCREASED 15 0.0002
837 TREMOR 38 0.0002
838 EOSINOPHILIA 4 0.0002
839 GASTRITIS 6 0.0002
840 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
841 BLOOD PRESSURE DECREASED 15 0.0002
842 TRANSAMINASES INCREASED 5 0.0002
843 TOOTH DISORDER 5 0.0002
844 HEPATOTOXICITY 5 0.0002
845 HAIR TEXTURE ABNORMAL 3 0.0002
846 ORAL PAIN 5 0.0002
847 LIMB INJURY 6 0.0002
848 PRODUCT QUALITY ISSUE 30 0.0002
849 HAEMORRHAGE 23 0.0002
850 ACUTE HEPATIC FAILURE 3 0.0002
851 SUICIDAL IDEATION 20 0.0002
852 RESPIRATORY DISTRESS 6 0.0002
853 BLOOD GLUCOSE ABNORMAL 4 0.0002
854 PROCEDURAL PAIN 6 0.0002
855 APHONIA 3 0.0002
856 THERAPEUTIC RESPONSE DECREASED 13 0.0002
857 BACTERIAL INFECTION 4 0.0002
858 BLINDNESS UNILATERAL 3 0.0002
859 EYE PAIN 12 0.0002
860 TARDIVE DYSKINESIA 6 0.0002
861 BLOOD SODIUM DECREASED 4 0.0002
862 RENAL FAILURE ACUTE 9 0.0002
863 VISION BLURRED 29 0.0002
864 FOOT FRACTURE 4 0.0002
865 PROTEINURIA 4 0.0002
866 MUSCULOSKELETAL DISORDER 4 0.0002
867 GLAUCOMA 4 0.0002
868 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
869 PRESYNCOPE 5 0.0002
870 UNDERDOSE 15 0.0002
871 PSYCHOTIC DISORDER 6 0.0002
872 CARDIAC DISORDER 19 0.0002
873 OSTEONECROSIS OF JAW 5 0.0002
874 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
875 SKIN EXFOLIATION 17 0.0002
876 SWELLING FACE 13 0.0002
877 PRODUCT ADHESION ISSUE 7 0.0002
878 RENAL DISORDER 9 0.0002
879 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
880 DISEASE RECURRENCE 9 0.0002
881 BRADYCARDIA 10 0.0002
882 FLUSHING 19 0.0002
883 HOT FLUSH 14 0.0002
884 INTESTINAL OBSTRUCTION 7 0.0002
885 PAIN OF SKIN 5 0.0002
886 DISTURBANCE IN ATTENTION 10 0.0002
887 BLOOD BILIRUBIN INCREASED 5 0.0002
888 ACNE 14 0.0002
889 INCORRECT DOSE ADMINISTERED 42 0.0002
890 DIABETES MELLITUS 14 0.0002
891 TREATMENT NONCOMPLIANCE 10 0.0002
892 CARDIAC ARREST 15 0.0002
893 VISUAL ACUITY REDUCED 6 0.0002
894 COAGULOPATHY 3 0.0002
895 FEELING ABNORMAL 43 0.0002
896 AGITATION 13 0.0002
897 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
898 SEIZURE 20 0.0002
899 DRUG INEFFECTIVE 228 0.0002
900 DYSSTASIA 5 0.0002
901 HEART RATE DECREASED 6 0.0002
902 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
903 LYMPHADENOPATHY 6 0.0002
904 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
905 CEREBRAL HAEMORRHAGE 6 0.0002
906 END STAGE RENAL DISEASE 3 0.0002
907 DRUG ADMINISTRATION ERROR 5 0.0002
908 ADVERSE EVENT 15 0.0002
909 ABASIA 4 0.0002
910 CONJUNCTIVITIS 3 0.0002
911 GYNAECOMASTIA 5 0.0002
912 THROMBOSIS 13 0.0002
913 VAGINAL HAEMORRHAGE 7 0.0002
914 HEPATIC FUNCTION ABNORMAL 6 0.0002
915 CONVULSION 9 0.0002
916 DRUG PRESCRIBING ERROR 3 0.0002
917 RASH GENERALISED 4 0.0002
918 OSTEONECROSIS 5 0.0002
919 LIP SWELLING 5 0.0001
920 FUNGAL INFECTION 5 0.0001
921 SKIN DISORDER 5 0.0001
922 IRRITABILITY 9 0.0001
923 FEAR 4 0.0001
924 BONE MARROW FAILURE 3 0.0001
925 NEUROPATHY PERIPHERAL 14 0.0001
926 GASTRIC DISORDER 5 0.0001
927 INTERSTITIAL LUNG DISEASE 7 0.0001
928 NEOPLASM PROGRESSION 5 0.0001
929 DISEASE PROGRESSION 17 0.0001
930 FLATULENCE 8 0.0001
931 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
932 THROAT IRRITATION 6 0.0001
933 BLOOD POTASSIUM DECREASED 4 0.0001
934 BLOOD GLUCOSE INCREASED 25 0.0001
935 LACRIMATION INCREASED 4 0.0001
936 EMOTIONAL DISORDER 4 0.0001
937 PLASMA CELL MYELOMA 5 0.0001
938 RENAL FAILURE 17 0.0001
939 EYE DISORDER 4 0.0001
940 STAPHYLOCOCCAL INFECTION 4 0.0001
941 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
942 AGEUSIA 3 0.0001
943 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
944 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
945 ANGER 4 0.0001
946 CARDIOVASCULAR DISORDER 3 0.0001
947 BREAST CANCER 11 0.0001
948 ANAPHYLACTIC SHOCK 3 0.0001
949 DEVICE DISLOCATION 5 0.0001
950 MYOCARDIAL INFARCTION 20 0.0001
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
952 MYELOSUPPRESSION 4 0.0001
953 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
954 DRUG EFFECT INCOMPLETE 4 0.0001
955 OCULAR HYPERAEMIA 5 0.0001
956 SURGERY 6 0.0001
957 CARDIAC FAILURE CONGESTIVE 8 0.0001
958 EMOTIONAL DISTRESS 12 0.0001
959 DEVICE BREAKAGE 4 0.0001
960 BLINDNESS 4 0.0001
961 BONE DENSITY DECREASED 3 0.0001
962 UNEVALUABLE EVENT 7 0.0001
963 EYE PRURITUS 3 0.0001
964 HOSPITALISATION 13 0.0001
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
966 BLOOD GLUCOSE DECREASED 4 0.0001
967 CRYING 3 0.0001
968 DRUG WITHDRAWAL SYNDROME 7 0.0001
969 PRODUCT DOSE OMISSION 5 0.0001
970 INJECTION SITE BRUISING 6 0.0001
971 INJECTION SITE HAEMORRHAGE 6 0.0001
972 DRY SKIN 10 0.0001
973 NEOPLASM MALIGNANT 5 0.0001
974 PRODUCT DOSE OMISSION ISSUE 22 0.0001
975 PROSTATE CANCER 6 0.0001
976 DRUG EFFECT DECREASED 4 0.0001
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
978 DRUG DOSE OMISSION 12 0.0001
979 DEATH 61 0.0001
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
981 EYE IRRITATION 4 0.0001
982 DEVICE LEAKAGE 3 0.0001
983 TOXICITY TO VARIOUS AGENTS 11 0.0001
984 ILLNESS 6 0.0001
985 SKIN BURNING SENSATION 4 0.0001
986 DEVICE ISSUE 5 0.0001
987 INJECTION SITE SWELLING 4 0.0001
988 NO ADVERSE EVENT 9 0.0000
989 INJECTION SITE PAIN 15 0.0000
990 DEVICE MALFUNCTION 3 0.0000
991 DRUG DEPENDENCE 4 0.0000